Journal article
Superoxide Enhances the Antitumor Combination of AdMnSOD Plus BCNU in Breast Cancer
Cancers, Vol.2(1), pp.68-87
03/2010
DOI: 10.3390/cancers2010068
PMCID: PMC2880814
PMID: 20532186
Abstract
Overexpression of manganese superoxide dismutase (MnSOD) can sensitize a variety of cancer cell lines to many anticancer drugs. Recent work has shown that cancer cells can be sensitized to cell killing by raising peroxide levels through increased manganese superoxide dismutase (MnSOD) when combined with inhibition of peroxide removal. Here we utilize the mechanistic property of one such anticancer drug, BCNU, which inhibits glutathione reductase (GR), compromising the glutathione peroxidase system thereby inhibiting peroxide removal. The purpose of this study was to determine if anticancer modalities known to produce superoxide radicals can increase the antitumor effect of MnSOD overexpression when combined with BCNU. To enhance MnSOD, an adenoviral construct containing the cDNA for
MnSOD
(Ad
MnSOD
) was introduced into human breast cancer cell line, ZR-75-1. Ad
MnSOD
infection alone did not alter cell killing, however when GR was inhibited with either BCNU or siRNA, cytotoxicity increased. Futhermore, when the Ad
MnSOD
+ BCNU treatment was combined with agents that enhance steady-state levels of superoxide (TNF-α, antimycin, adriamycin, photosensitizers, and ionizing radiation), both cell cytotoxicity and intracellular peroxide levels increased. These results suggest that the anticancer effect of Ad
MnSOD
combined with BCNU can be enhanced by agents that increase generation of superoxide.
Details
- Title: Subtitle
- Superoxide Enhances the Antitumor Combination of AdMnSOD Plus BCNU in Breast Cancer
- Creators
- Wenqing G Sun - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsChristine J Weydert - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsYuping Zhang - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsLei Yu - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsJingru Liu - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsDouglas R Spitz - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsJoseph J Cullen - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-MailsLarry W Oberley - Free Radical and Radiation Biology Program, Department of Radiation Oncology, Holden Comprehensive Cancer Center, Iowa City, IA, USA; E-Mails
- Resource Type
- Journal article
- Publication Details
- Cancers, Vol.2(1), pp.68-87
- DOI
- 10.3390/cancers2010068
- PMID
- 20532186
- PMCID
- PMC2880814
- NLM abbreviation
- Cancers (Basel)
- ISSN
- 2072-6694
- eISSN
- 2072-6694
- Publisher
- Molecular Diversity Preservation International
- Language
- English
- Date published
- 03/2010
- Academic Unit
- Pathology; Surgery; Radiation Oncology; Obstetrics and Gynecology
- Record Identifier
- 9984046817902771
Metrics
16 Record Views